Thrombocytopenic purpura as adverse reaction to recombinant hepatitis B vaccine

Arch Dis Child. 1998 Mar;78(3):273-4. doi: 10.1136/adc.78.3.273.

Abstract

Three cases of immune thrombocytopenic purpura after the first dose of recombinant hepatitis B vaccine occurred in infants under 6 months of age. Other possible causes of this condition were excluded. Antiplatelet antibodies were present. A defect in platelet production was excluded in two children. Corticosteroid treatment was effective. Subsequent administration of other vaccines (against polio, diphtheria, and tetanus) did not cause relapse of thrombocytopenia.

Publication types

  • Case Reports

MeSH terms

  • Autoantibodies / blood
  • Blood Platelets / immunology
  • Female
  • Hepatitis B Vaccines / adverse effects*
  • Humans
  • Infant
  • Male
  • Purpura, Thrombocytopenic, Idiopathic / etiology*
  • Purpura, Thrombocytopenic, Idiopathic / immunology
  • Vaccines, Synthetic / adverse effects*

Substances

  • Autoantibodies
  • Hepatitis B Vaccines
  • Vaccines, Synthetic